So it wasn't simple opportunism by SI then?
What happened to the share price when MSB announced the trial?
Who said it "flew through" the interim analysis?
What happened to the share price when SI announced the agreement with Novartis over the Covid trial?
What about all the social media chatter that the trial would soon be stopped for "overwhelming efficacy"?
Where was the admission by the company that it was stopped because the trial failed a the futility test?
Did they really claim that the trial was "completed"?
Why did it take Novartis so long to evaluate the evidence?
Why did Novartis walk away from the deal with MSB?
What was the reason MSB gave in the announcement for Novartis walking away from the agreement?
IMO lots of questions for investors to think about.
CHF - MSB's Dark Horse with Multi-billion dollar potential, page-328
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.010(0.92%) |
Mkt cap ! $1.233B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.11 | $1.05 | $5.002M | 4.632M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5697 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
-0.010 ( 0.10 %) |
||||
| Open | High | Low | Volume | ||
| $1.09 | $1.11 | $1.06 | 1181223 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| MSB (ASX) Chart |